Group 1 - The company, Shumeng Capital (08375.HK), announced a placement agreement with a placement agent to issue up to 57.6 million shares at a price of HKD 0.99 per share [1] - The placement is subject to approval from the listing committee for the shares to be listed and traded [1] - The number of shares to be placed represents approximately 20.00% of the company's existing issued share capital as of the announcement date [1] Group 2 - The placement price of HKD 0.99 per share reflects a discount of approximately 19.51% compared to the last closing price of HKD 1.23 per share [1] - If fully placed, the net proceeds from the placement, after deducting all applicable costs and expenses, including placement commissions and fees, will be approximately HKD 55.784 million, resulting in a net price of about HKD 0.968 per share [1]

Core Viewpoint - SenseTime-W (00020) has successfully completed the placement of shares as per the terms of the placement agreement, with all conditions met by December 29, 2025 [1] Group 1 - The placement agent has successfully placed a total of 1.75 billion shares at a price of HKD 1.80 per share to no less than six subscribers [1] - The shares placed represent approximately 4.60% of the issued B shares prior to the completion of the placement and about 4.52% of the total issued shares [1] - After the issuance of the placement shares, the enlarged issued B shares will represent approximately 4.40% and the total issued shares will represent about 4.33% [1]

Core Viewpoint - Sterling GP (01825) has announced a placement agreement with a placement agent to issue up to 69.12 million shares at a price of HKD 0.10 per share, representing 20% of the existing issued share capital as of the announcement date [1] Group 1 - The placement shares will be offered to at least six independent third-party subscribers [1] - The placement price of HKD 0.10 per share is approximately 7.5% higher than the closing price of HKD 0.093 on December 29, 2025 [1] - The total expected proceeds from the placement are approximately HKD 6.91 million, with a net amount of about HKD 6.77 million after deducting related expenses [1] Group 2 - The net proceeds from the placement are intended to be used for general working capital purposes [1]

Core Viewpoint - The company Capital界金控 (00204) has announced a placement agreement to issue up to 41.5092 million new shares at a price of HKD 0.183 per share, representing a discount of approximately 2.14% from the closing price of HKD 0.187 on December 24, 2025 [1] Group 1 - The maximum number of shares to be placed is 41.5092 million, which accounts for about 20% of the company's total issued share capital of 207.5 million shares as of the announcement date [1] - The net proceeds from the placement are estimated to be approximately HKD 7.36 million, assuming full placement and after deducting all related expenses [1] - The funds raised will be used for potential investment opportunities that may arise in the future [1]

认购价每股认购股份0.245港元较联交所所报的收市价每股0.300港元折让约18.33%；认购股份将根据将 于股东特别大会上自独立股东(不包括(对就与特别授权相关的决议案投票而言)认购人III及其联系人)获 得的特别授权配发及发行。公司将向联交所上市委员会申请批准认购股份于联交所上市及买卖。 格隆汇12月24日丨能源国际投资(00353.HK)公告，于2025年12月24日，公司(作为发行人)分别与认购人 孙可、 Cosmic Shine International Limited及王卉霖订立三份认购协议，据此，认购人已有条件同意按认 购价每股认购股份0.245港元认购而公司已有条件同意配发及发行合共10.35亿股认购股份，代价总额为 2.54亿港元。 ...

假设所有配售股份获悉数配售，配售事项所得款项总额将约为6960万港元，而扣除配售佣金及相关开支 后的所得款项净额将约为6860万港元(每股配售股份净价0.429港元)。 假设于本公布日期至配售事项完成期间公司已发行股本并无变动，则配售事项项下最多1.6亿股配售股 份分别相当于本公布日期公司现有已发行股本约10.67%;及经配发及发行配售股份扩大后公司已发行股 本约9.64%。 润歌互动(02422)发布公告，于2025年12月23日，公司与盈宝证券国际(香港)有限公司(配售代理)订立有 条件配售协议，根据配售协议，配售代理同意作为公司的代理，在配售协议所载条款及条件规限下，按 尽力基准促使不少于六名承配人(其本身及其最终实益拥有人均为独立第三方)按每股配售股份0.435港元 的配售价认购最多1.6亿股公司新股份(配售股份)。每股配售股份0.435港元的配售价较于配售协议日期 联交所所报每股股份收市价0.54港元折让约19.44%。 ...

配售事项项下最多1.6亿股配售股份分别相当于本公布日期公司现有已发行股本约10.67%；每股配售股 份0.435港元的配售价较于配售协议日期联交所所报每股股份收市价0.54港元折让约19.44%；及预期配 售事项的所得款项最高总额及所得款项净额(扣除配售佣金及相关开支后)将分别为约6960万港元及6860 万港元。配售事项的所得款项净额将用于以下用途：(1)约20%将用于企业私域流量行销服务业务发展及 扩展；(2)约80%将用于补充公司的一般营运资金。 格隆汇12月23日丨润歌互动(02422.HK)公告，于2025年12月23日，公司与盈宝证券国际(香港)有限公司 ("配售代理")订立有条件配售协议，根据配售协议，配售代理同意作为公司代理，在配售协议所载条款 及条件规限下，按尽力基准促使不少于六名承配人(其本身及其最终实益拥有人均为独立第三方)按每股 配售股份0.435港元配售价认购最多1.6亿股公司新股份。 ...

香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）及香港中央結算有限公司（「香港結算」）對本公 告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而 產生或因倚賴該等內容而引致的任何損失承擔任何責任。 除本公告另有界定者外，本公告所用詞彙與輕松健康集團（「本公司」）刊發的日期為2025年12月15日的招股章程 （「招股章程」）所界定者具有相同涵義。 本公告僅供參考，並不構成任何人士收購、購買或認購本公司任何證券的要約或誘使作出要約的邀請。本公告並 非招股章程。有意投資者應先行閱讀招股章程有關下文所述本公司及全球發售的詳細資料，方決定是否投資於發 售股份。有關發售股份的任何投資決定應僅依賴招股章程所提供的資料而作出。 本公告不會直接或間接於美國或向美國（包括其領土及屬地、美國任何州及哥倫比亞特區）發佈、刊發或派發。本 公告並非且不擬構成或組成在美國或任何其他司法管轄區的任何要約出售或招攬購買或認購任何證券的一部分。 發售股份並無亦不會根據1933年美國證券法（經不時修訂）（「美國證券法」）或美國任何州或其他司法管轄區的證券 法登記，且不得於美國境內提呈發 ...

智通财经APP讯，超大现代(00682)发布公告，配售协议所载的所有条件已于2025年12月17日获达成，而 配售事项的完成已根据配售协议的条款及条件于2025年12月19日作实。根据配售协议，公司已根据一般 授权按每股配售股份0.225港元的配售价向不少于六名承配人(该等承配人及其最终实益拥有人将为独立 于公司及其关连人士的第三方)配发及发行合共3295万股配售股份，相当于本公告日期公司已发行股本 (经配发及发行配售股份扩大)约16.67%。配售事项所得款项净额(经扣除配售佣金及其他相关开支)约为 719万港元。 ...

New IPOs - The largest biotech IPO in Hong Kong for 2025 is initiated by Insilico Medicine (03696), which boasts the fastest global progress in AI drug development [1] - Lin Qingxuan (02657) will conduct its IPO from December 18 to December 23, attracting cornerstone investors like Fidelity [1] - Woan Robotics (06600) is set to launch its IPO during the same period, with an expected listing date of December 30 [1] - Meilian Holdings (02671) and Wuyi Vision (06651) will also hold their IPOs from December 18 to December 23, both expected to list on December 30 [1] - Xun Ce (03317) will follow the same IPO schedule, with a listing anticipated on December 30 [1] - Zhihui Mining (02546) achieved a remarkable 5248.15 times subscription in its public offering, with a listing date of December 19 [1] - China National Airlines (00753) plans to invest in Shenzhen Airlines' equity financing, with Kunhang Investment, a state-owned entity, being shortlisted [1] - Sensetime-W (00020) intends to place 1.75 billion new Class B shares, aiming to raise approximately HKD 3.146 billion [1] - Fosun Pharma (02196) is enhancing its overseas innovative drug strategy by signing a cooperation and option agreement with Clavis Bio [1] - WuXi AppTec (02359) invested around EUR 30 million to acquire a 3.22% stake in a French biopharmaceutical fund [1] - Minhua Holdings (01999) plans to acquire 100% equity in the American soft furniture company Gainline Recline Intermediate Corp [1] Share Buybacks - Tencent Holdings (00700) repurchased 1.055 million shares for HKD 636 million on December 18 [2] - Xiaomi Group-W (01810) spent HKD 151 million to buy back 3.75 million shares on the same day [2] - COSCO Shipping Holdings (01919) repurchased 5.9 million shares for HKD 80.557 million [2] - Country Garden Services (06098) bought back 2.7 million shares for HKD 17.136 million [2] - Jiangsu Ninghu Expressway (00177) saw an increase of 52.862 million shares by Yunsong Capital [2]